3,4-Dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxamide
Selected Variant
HY-152604
Size: 5 mg
3,4-Dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxamide is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
356782-84-8
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/3-4-dihydro-3-oxo-4-β-d-ribofuranosyl-2-pyrazinecarboxamide.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C=CN=C(C(N)=O)C2=O)O1
Molecular Formula
C10H13N3O6
Molecular Weight
271.23
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-NOTCH4 Antibody Picoband®, iFluor647 Conjugate
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/2729R), CF568 conjugate, 0.1mg/mL
Estrogen Receptor (ER505), CF568 conjugate, 0.1mg/mL
